As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
DNAnexus operates a cloud platform for managing and analysing genomic and biomedical data at national scale. Founded in 2009 in California, it hosts large research cohorts including the UK Biobank research analysis platform. Its environment lets thousands of scientists run machine learning workflows on data that never leaves compliance boundaries.
News
Report
Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource
Naturally occurring loss-of-function variants in human genes enable drug target discovery because they mimic pharmacological inhibition of proteins. However, the study of these genetic variants is constrained by their rarity. Sequencing of diverse populat
Read more
Report
Programming biology: next-gen AI firms raise billions to design better medicines
Faster drug discovery, optimized drug design, even programmable therapeutics: AI is impacting R&D. Data and development bottlenecks remain.
Read more
Report
2023 Bio-IT World Innovative Practices Awards Winner for City of Hope's POSEIDON - Precision Oncology Software Environment Interoperable Data Ontologies Network. Built on the DNAnexus technology stack with custom features and functionality created by City of Hope Research Informatics, POSEIDON unifies patient data and comprehensive germline and somatic genomic profiling for every patient, supporting data from more than 670,000 patients. POSEIDON enables de-identified and harmonized clinical and multi-omic d
Read more
Report
Pro access
Upgrade to see all 25 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
